DOCSLIB.ORG

Summary of Notifiable Diseases — United States, 2004

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Summary of Notifiable Diseases — United States, 2004 Morbidity and Mortality Weekly Report Weekly Published June 16, 2006, for 2004 / Vol. 53 / No. 53 Summary of Notifiable Diseases — United States, 2004 department of health and human services Centers for Disease Control and Prevention MMWR CONTENTS The MMWR series of publications is published by the Coordinating Center for Health Information and Service, Centers Preface .................................................................................2 for Disease Control and Prevention (CDC), U.S. Department of Background ..........................................................................2 Health and Human Services, Atlanta, GA 30333. Infectious Diseases Designated as Notifiable at the National SUGGESTED CITATION Level During 2004 ............................................................3 Centers for Disease Control and Prevention. Summary of Data Sources ........................................................................4 notifiable diseases—United States, 2004. Published June 16, 2006, for MMWR 2004;53(No. 53):[inclusive page Interpreting Data ..................................................................5 numbers]. Transition in NNDSS Data Collection and Reporting .............5 Highlights .............................................................................6 PART 1. Summaries of Notifiable Diseases in the United Centers for Disease Control and Prevention States, 2004 ................................................................... 17 Julie L. Gerberding, MD, MPH Director TABLE 1. Reported cases of notifiable diseases, by total cases, rank of the total cases, and rate (per 100,000 Dixie E. Snider, MD, MPH Chief Science Officer population) — United States, 2004 ..............................18 TABLE 2. Reported cases of notifiable diseases, by Tanja Popovic, MD, PhD geographic division and area — United States, 2004 ... 20 Associate Director for Science TABLE 3. Reported cases and incidence of notifiable Coordinating Center for Health Information and Service diseases, by age group — United States, 2004 ............29 Steven L. Solomon, MD TABLE 4. Reported cases and incidence of notifiable Director diseases, by sex — United States, 2004 ....................... 31 TABLE 5. Reported cases and incidence of notifiable National Center for Health Marketing diseases, by race — United States, 2004 ......................33 Jay M. Bernhardt, PhD, MPH Director TABLE 6. Reported cases and incidence of notifiable diseases, by ethnicity — United States, 2004 ............... 35 Division of Scientific Communications TABLE 7. Deaths from selected notifiable diseases — Judith R. Aguilar (Acting) Director United States, 2002 ..................................................... 37 PART 2. Graphs and Maps for Selected Notifiable Diseases Mary Lou Lindegren, MD Editor, MMWR Series in the United States, 2004 ..............................................39 Selected Reading ............................................................... 71 Suzanne M. Hewitt, MPA Managing Editor, MMWR Series Teresa F. Rutledge Lead Technical Writer/Editor Jeffrey D. Sokolow, MA Project Editor Lynda G. Cupell Visual Information Specialist Quang M. Doan, MBA Erica R. Shaver Information Technology Specialists Vol. 53 / No. 53 MMWR 1 Summary of Notifiable Diseases — United States, 2004 Prepared by Ruth Ann Jajosky, DMD Patsy A. Hall, Annual Summary Coordinator Deborah A. Adams Felicia J. Dawkins Pearl Sharp Willie J. Anderson J. Javier Aponte Gerald F. Jones David A. Nitschke Carol A. Worsham Nelson Adekoya, DrPH Timothy Doyle, MPH National Center for Public Health Informatics, Coordinating Center for Health Information and Service, CDC 2 MMWR June 16, 2006 Preface Background The Summary of Notifiable Diseases — United States, 2004 The infectious diseases designated as notifiable at the contains the official statistics, in tabular and graphic form, national level during 2004 are listed on page 3. A notifi- for the reported occurrence of nationally notifiable infec- able disease is one for which regular, frequent, and timely tious diseases in the United States for 2004. Unless other- information regarding individual cases is considered neces- wise noted, the data are final totals for 2004 reported as of sary for the prevention and control of the disease. A brief December 2, 2005. These statistics are collected and com- history of the reporting of nationally notifiable infectious piled from reports sent by state health departments to the diseases in the United States is available at http:// National Notifiable Diseases Surveillance System (NNDSS), www.cdc.gov/epo/dphsi/nndsshis.htm. In 1961, CDC which is operated by CDC in collaboration with the Coun- assumed responsibility for the collection and publication cil of State and Territorial Epidemiologists (CSTE). The of data on nationally notifiable diseases. NNDSS is neither Summary is available at http://www.cdc.gov/mmwr/ a single surveillance system nor a method of reporting. Cer- summary.html. This site also includes publications from tain NNDSS data are reported to CDC through separate previous years. surveillance information systems and through different The Highlights section presents noteworthy epidemio- reporting mechanisms; however, these data are aggregated logic and prevention information for 2004 for selected dis- and compiled for publication purposes. eases and additional information to aid in the interpretation The list of nationally notifiable diseases is revised peri- of surveillance and disease-trend data. Part 1 contains tables odically. A disease might be added to the list as a new patho- showing incidence data for the nationally notifiable dis- gen emerges, or a disease might be deleted as its incidence eases during 2004.* The tables provide the number of cases declines. Public health officials at state health departments reported to CDC for 2004 nationwide as well as the distri- and CDC collaborate in determining which diseases should bution of cases by geographic location and the patient’s be nationally notifiable. CSTE, with input from CDC, demographic characteristics (age, sex, race, and ethnicity). makes recommendations annually for additions and dele- Part 2 contains graphs and maps that depict summary data tions. Although disease reporting is mandated by legisla- for certain notifiable diseases described in tabular form in tion or regulation at the state and local levels, state reporting Part 1. The Selected Reading section presents general and to CDC is voluntary. Thus, the list of diseases considered disease-specific references for notifiable infectious diseases. notifiable varies slightly by state. Current and historic These references provide additional information on surveil- national public health surveillance case definitions used for lance and epidemiologic concerns, diagnostic concerns, and classifying and enumerating cases consistently across report- ing jurisdictions are available at http://www.cdc.gov/epo/ disease-control activities. dphsi/nndsshis.htm. Comments and suggestions from readers are welcome. To All states report conditions that were designated as inter- increase the usefulness of future editions, comments about nationally quarantinable and notifiable (i.e., cholera, plague, the current report and descriptions about how information and yellow fever) in compliance with the International is or could be used are invited. Comments should be sent Health Regulations (IHR) issued by the World Health to Public Health Surveillance Team — NNDSS, National Organization (WHO). In May 2005, the World Health Center for Public Health Informatics at [email protected]. Assembly adopted revised IHR. The current IHR will be replaced by the 2005 IHR when it becomes official on June * Because no cases of anthrax; diphtheria; influenza-associated pediatric mortality; 15, 2007, unless an earlier implementation date is adopted. paralytic poliomyelitis; rubella, congenital syndrome; severe acute respiratory syndrome–associated coronavirus (SARS-CoV) disease; smallpox; vancomycin- The 2005 IHR revision stipulates that smallpox, poliomy- intermediate Staphylococcus aureus; western equine encephalitis; or yellow fever elitis caused by wild-type poliovirus, human influenza caused were reported in the United States during 2004, these diseases do not appear in by a new subtype, and SARS-CoV are directly reportable the tables in Part 1. For certain other nationally notifiable diseases, incidence data were reported to CDC but are not included in the tables or graphs of this to WHO. In addition, the 2005 IHR includes an open- Summary. Data on chronic hepatitis B and hepatitis C virus infection (past or ended algorithm to determine which other conditions or present) are undergoing data quality review. Data on ehrlichiosis attributable to events require mandatory reporting to WHO because they other or unspecified agents are being withheld from publication pending the outcome of discussions about the reclassification of certain Ehrlichia species, might constitute a public health emergency of international which will probably affect how data in this category are reported. Data on concern. Conditions that use the algorithm to determine human immunodeficiency virus (HIV) infections are not included because notifiability include, but are not limited to, cholera, pneu- HIV infection (not acquired immunodeficiency syndrome [AIDS]) reporting has been implemented on different dates and by using different monic plague, yellow fever, and West Nile fever (1). methods than for AIDS case reporting;
Load more

Recommended publications
  • Shigellosis Infection with S
    lasting about a week. The tropical forms cause more severe illnesses. Symptoms usually last 2‐ 4 weeks. Shigellosis Infection with S. dysenteriae tends to be severe and (Notifiable) prolonged and requiring hospital admission. Toxic megacolon is occasionally seen in disease caused by S. Description: Shigellosis produces a classical dysenteriae Type I. Infection with S. flexneri can lead to gastroenteritis with pronounced, occasionally bloody, Reiter’s Syndrome (reactive post‐infectious diarrhoea. About one third of cases are foodborne. arthropathy). HUS is a recognised complication of bacillary dysentery (it is closely associated with infection Annual Numbers: Between 40 and 80 cases per year. due to S. dysenteriae Type I) and is more likely to develop if amoxicillin is given during the diarrhoeal Seasonal Distribution: There is no seasonal pattern of phase. The case fatality rate with S. dysenteriae Type I is incidence. between 20 and 40% even in developed countries. Causative Agent: The causative agents of shigellosis are Clinical Management of Cases Shigella sonnei, Shigella boydii, Shigella dysenteriae and Enteric precautions including hygiene advice. The case Shigella flexneri. S. sonnei and S. dysenteriae each should be notified to the local Department of Public account for about 40% of cases. About 40% of cases Health. It is important to determine if the case is aware report recent travel to Africa. Fewer than 10% of cases of similar cases suggesting the possibility of an outbreak. did not travel outside Ireland. Determine if case is in a risk category. Reservoir: The gastrointestinal tracts of humans and Public Health Management of Cases (occasionally) apes. Enteric precautions including hygiene advice.
    [Show full text]
  • Detection of Shigella Spp. and Enteroinvasive Escherichia Coli MALABI VENKATESAN,* JERRY M
    JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1988, p. 261-266 Vol. 26, No. 2 0095-1137/88/020261-06$02.00/0 Copyright ©D 1988, American Society for Microbiology Development and Testing of Invasion-Associated DNA Probes for Detection of Shigella spp. and Enteroinvasive Escherichia coli MALABI VENKATESAN,* JERRY M. BUYSSE, ERIC VANDENDRIES, AND DENNIS J. KOPECKO Department ofBacterial Immunology, Division of Communicable Diseases and Immunology, Walter Reed Army Institute ofResearch, Washington, D.C. 20307-5100 Received 29 June 1987/Accepted 29 October 1987 Genetic determinants of the invasive phenotype of Shigeila spp. and enteroinvasive Escherichia coli (EIEC), two common agents of bacillary dysentery, are encôded on large (180- to 210 kilobase), nonconjugative plasmids. Several plasmid-encoded antigens have been implicated as important bacterial ligands that mediate the attachment and invasion of colonic epithelial cells by the bacteria. Selected invasion plasmid antigen (ipa) genes have recently been cloned from Shigellaflexneri serotype 5 into the X gtll expression vector. Portions of three ipa genes (ipaB, ipaC, and ipaD) were tested as DNA probes for diagnostic detection of bacillary dysentery. Undér stringent DNA hybridization conditions, all three DNA sequences hybridized to a single 4.6-kilobase HindIII fragment of the invasion plasmids of representative virulent Shigella spp. and EIEC strains. No hybridization was detected in isogenic, noninvasive Shigella mutants which had lost the invasion plasmid or had deleted the ipa gene region. Furthermore, these probes did not react with over 300 other enteric and nonenteric gram-negative bacteria tested, including Salmonella, Yersinia, Edwardsiella, Campylobacter, Vibrio, Klebsiella, Aeromonas, Enterobacter, Rickettsia, and Citrobacter spp. and various pathogenic E.
    [Show full text]
  • Electronic Laboratory Reporting Use Case January 2011
    ILLINOIS HEALTH INFORMATION EXCHANGE Electronic Laboratory Reporting Use Case Electronic Laboratory Reporting and Health Information Exchange Illinois Health Information Exchange Public Health Work Group January 2011 Electronic Laboratory Reporting Use Case January 2011 Table of Contents 1.0 Executive Summary……………………………………………………………………….3 2.0 Introduction…………………………………………………………………...……………..5 3.0 Scope……………………………………..………………………………………………………5 4.0 Use Case Stakeholders…………………………………………………………….….....6 5.0 Issues and Obstacles……………………………………………………………………...8 6.0 Use Case Pre-Conditions .………………….…………………………………………...8 7.0 Use Case Post-Conditions.……………………………………………………………...9 8.0 Detailed Scenarios/Technical Specifications.………………………………10 9.0 Validation and Certification………………………………………………………...12 Appendix ………………………………………………………………………………………….....13 Page 2 Electronic Laboratory Reporting Use Case January 2011 1.0 Executive Summary This Use Case is a product of the Public Health Work Group (PHWG) of the Illinois Health Information Exchange (HIE) Advisory Committee. The Illinois HIE Advisory Committee was constituted as the diverse public healthcare stakeholder body providing input and recommendations on the creation of the Illinois Health Information Exchange Authority (“the Authority”) as the Illinois vehicle for designing and implementing electronic health information exchange in Illinois. The establishment of the Authority marks the formal transition of the work of the HIE Advisory Committee and the Work Groups into alignment with the provisions of Illinois
    [Show full text]
  • International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/Ijsem.0.001485
    International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/ijsem.0.001485 Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Mobolaji Adeolu,† Seema Alnajar,† Sohail Naushad and Radhey S. Gupta Correspondence Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Radhey S. Gupta L8N 3Z5, Canada [email protected] Understanding of the phylogeny and interrelationships of the genera within the order ‘Enterobacteriales’ has proven difficult using the 16S rRNA gene and other single-gene or limited multi-gene approaches. In this work, we have completed comprehensive comparative genomic analyses of the members of the order ‘Enterobacteriales’ which includes phylogenetic reconstructions based on 1548 core proteins, 53 ribosomal proteins and four multilocus sequence analysis proteins, as well as examining the overall genome similarity amongst the members of this order. The results of these analyses all support the existence of seven distinct monophyletic groups of genera within the order ‘Enterobacteriales’. In parallel, our analyses of protein sequences from the ‘Enterobacteriales’ genomes have identified numerous molecular characteristics in the forms of conserved signature insertions/deletions, which are specifically shared by the members of the identified clades and independently support their monophyly and distinctness. Many of these groupings, either in part or in whole, have been recognized in previous evolutionary studies, but have not been consistently resolved as monophyletic entities in 16S rRNA gene trees. The work presented here represents the first comprehensive, genome- scale taxonomic analysis of the entirety of the order ‘Enterobacteriales’.
    [Show full text]
  • Characterization and Genome Structure of Virulent Phage Espm4vn to Control Enterobacter Sp
    fmicb-11-00885 May 30, 2020 Time: 19:18 # 1 ORIGINAL RESEARCH published: 03 June 2020 doi: 10.3389/fmicb.2020.00885 Characterization and Genome Structure of Virulent Phage EspM4VN to Control Enterobacter sp. M4 Isolated From Plant Soft Rot Nguyen Cong Thanh1,2, Yuko Nagayoshi1, Yasuhiro Fujino1, Kazuhiro Iiyama3, Naruto Furuya3, Yasuaki Hiromasa4, Takeo Iwamoto5 and Katsumi Doi1* 1 Microbial Genetics Division, Institute of Genetic Resources, Faculty of Agriculture, Kyushu University, Fukuoka, Japan, 2 Plant Protection Research Institute, Hanoi, Vietnam, 3 Laboratory of Plant Pathology, Faculty of Agriculture, Kyushu University, Fukuoka, Japan, 4 Attached Promotive Center for International Education and Research of Agriculture, Faculty of Agriculture, Kyushu University, Fukuoka, Japan, 5 Core Research Facilities for Basic Science, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan Enterobacter sp. M4 and other bacterial strains were isolated from plant soft rot disease. Virulent phages such as EspM4VN isolated from soil are trending biological controls for Edited by: plant disease. This phage has an icosahedral head (100 nm in diameter), a neck, and a Robert Czajkowski, University of Gdansk,´ Poland contractile sheath (100 nm long and 18 nm wide). It belongs to the Ackermannviridae Reviewed by: family and resembles Shigella phage Ag3 and Dickeya phages JA15 and XF4. We report ◦ ◦ Konstantin Anatolievich herein that EspM4VN was stable from 10 C to 50 C and pH 4 to 10 but deactivated Miroshnikov, at 70◦C and pH 3 and 12. This phage formed clear plaques only on Enterobacter sp. Institute of Bioorganic Chemistry (RAS), Russia M4 among tested bacterial strains.
    [Show full text]
  • Shigella Species
    INTERNATIONAL JOURNAL of SYSTEMATIC BACTERIOLOGY Vol. 23, No. 1 January 1973, P. 1-7 Printed in U.S.A. Copyright 0 1973 International Association of Microbiological Societies P oly nucleo tide Sequence Relatedness Among Shigella Species DON J. BRENNER, G. R. FANNING, G. V. MIKLOS, and A. G. STEIGERWALT Division of Biochemistry, Walter Reed Army Institute of Research, Washington, D. C 20012 Polynucleotide sequence relatedness in strains of Shigella species was assessed by determining the extent of reassociation in heterologous deoxyribonucleic acid preparations. Thermal elution chromatography on hydroxyapatite was used to separate reassociated nucleotide sequences from nonreassociated sequences and to determine the degree of unpaired bases within related nucleotide sequences. Almost all Shigella strains share 80% or more of their nucleotide sequences. Less than 3% of unpaired bases are present in these related sequences. The same extent of relatedness is present between Shigella and Escherichia coli strains. Strains of S. boydii C13 are highly interrelated. These strains average only about 65% relatedness to other Escherichieae. We were unable to detect preferentially high relatedness between those Shigella and E. coli strains that contain identical or related 0 antigens. The tribe Escherichieae Bergey et al. (9) MATERIALS AND METHODS contains two genera, Escherichia Castellani and Chalmers and Shigella Castellani and Chalmers. Organisms and media. The strains used in this study These genera are highly related based on are listed in Table 1. Cultures of these organisms were biochemical reactions (8), serological cross- maintained on brain heart infusion agar slants and reactions (8), amino acid sequence similarity in were propagated on brain heart infusion broth.
    [Show full text]
  • DMST Catalogue
    NIH 019 Version 2 (ปรับปรุงครั้งที่ 2) 24 กรกฏาคม 2563 กค.2563 Other Number Genus species DMST Type designation 1 Acinetobacter baumannii 2271 Bacteria 2 Acinetobacter baumannii 10437 Bacteria 3 Acinetobacter baumannii 43250 Bacteria 4 Acinetobacter calcoaceticus 10436 Bacteria 5 Acinetobacter junii 2274 Bacteria 6 Acinetobacter junii 10440 Bacteria 7 Acinetobacter lwoffii 2277 Bacteria 8 Aeromonas caviae 25498 Bacteria 9 Aeromonas hydrophila 2798 Bacteria 10 Aeromonas hydrophila 21250 Bacteria 11 Aeromonas hydrophila 25194 Bacteria 12 Aeromonas sobria 12440 Bacteria 13 Aeromonas sobria 25185 Bacteria 14 Aeromonas trota 21254 Bacteria 15 Aeromonas veronii bv. veronii 21255 Bacteria 16 Aspergillus brasiliensis (niger)* 15538 Fungi 17 Bacillus cereus 5040 Bacteria 18 Bacillus cereus 6229 Bacteria 19 Bacillus cereus 12126 Bacteria 20 Bacillus cereus 12127 Bacteria 21 Bacillus cereus 16007 Bacteria 22 Bacillus mycoides 22391 Bacteria 23 Bacillus subtilis 5871 Bacteria 25 Bacillus subtilis 15896 Bacteria 26 Bacillus thuringiensis 22971 Bacteria 27 Bacillus thuringiensis 22974 Bacteria 28 Bacillus thuringiensis 53003 Bacteria 29 Bacteroides fragilis * 19152 Bacteria 30 Bacteroides vulgatus * 15535 Bacteria หมายเหตุ : * = เป็นเชื้อเจริญช้า อาจใช้เวลาในการเตรียมเชื้อส าหรับให้บริการมากกว่า 23 วันท าการ DMST = Department of Medical Sciences Thailand Tel. 02-9510000 ext. 99408, 99443, 02-9510183, Email : [email protected] 2 Other Number Genus species DMST Type designation 31 Bordetella bronchiseptica 16963 Bacteria 32 Burkholderia
    [Show full text]
  • Short Genome Report of Cellulose-Producing Commensal Escherichia Coli 1094
    Bernal-Bayard et al. Standards in Genomic Sciences (2018) 13:13 https://doi.org/10.1186/s40793-018-0316-0 SHORTGENOMEREPORT Open Access Short genome report of cellulose- producing commensal Escherichia coli 1094 Joaquin Bernal-Bayard1*, Laura Gomez-Valero2,3, Aimee Wessel1, Varun Khanna4, Christiane Bouchier5 and Jean-Marc Ghigo1* Abstract Bacterial surface colonization and biofilm formation often rely on the production of an extracellular polymeric matrix that mediates cell-cell and cell-surface contacts. In Escherichia coli and many Betaproteobacteria and Gammaproteobacteria cellulose is often the main component of the extracellular matrix. Here we report the complete genome sequence of the cellulose producing strain E. coli 1094 and compare it with five other closely related genomes within E. coli phylogenetic group A. We present a comparative analysis of the regions encoding genes responsible for cellulose biosynthesis and discuss the changes that could have led to the loss of this important adaptive advantage in several E. coli strains. Data deposition: The annotated genome sequence has been deposited at the European Nucleotide Archive under the accession number PRJEB21000. Keywords: E. coli, Commensal, Biofilm, Cellulose, Extracellular matrix, Bcs operon Introduction Organism information Biofilms are ubiquitous microbial communities growing in Classification and features close association with surfaces present in natural and Escherichia coli is a Gram-negative, rod-shaped, non-spore anthropic environments [1]. Biofilm bacteria often self- forming and facultative anaerobic species belonging to the assemble by producing a cohesive extracellular matrix that Enterobacteriaceae family. They are commonly found in protects these multicellular aggregates against environmen- the intestines of endotherms and are taxonomically placed tal changes and maintains the integrity of the biofilm struc- within the Gammaproteobacteria of the Proteobacteria ture [2].
    [Show full text]
  • Identification of Shigella Species
    UK Standards for Microbiology Investigations 2013 Identification of Shigella species DECEMBER 13 - NOVEMBER 15 BETWEEN ON CONSULTED WAS DOCUMENT THIS - DRAFT Issued by the Standards Unit, Microbiology Services, PHE Bacteriology – Identification | ID 20 | Issue no: di+ | Issue date: dd.mm.yy <tab+enter> | Page: 1 of 20 © Crown copyright 2013 Identification of Shigella species Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website http://www.hpa.org.uk/SMI/Partnerships. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see http://www.hpa.org.uk/SMI/WorkingGroups). The contributions of many individuals in clinical, specialist and reference laboratories2013 who have provided information and comments during the development of this document are acknowledged. We are grateful to the Medical Editors for editing the medical content. For further information please contact us at: DECEMBER 13 Standards Unit - Microbiology Services Public Health England 61 Colindale Avenue London NW9 5EQ NOVEMBER E-mail: [email protected] 15 Website: http://www.hpa.org.uk/SMI UK Standards for Microbiology Investigations are produced in association with: BETWEEN ON CONSULTED WAS DOCUMENT THIS - DRAFT Bacteriology – Identification | ID 20 | Issue no: di+ | Issue date: dd.mm.yy <tab+enter> | Page: 2 of 20 UK Standards for Microbiology Investigations | Issued by the Standards Unit, Public Health England Identification of Shigella species Contents ACKNOWLEDGMENTS .......................................................................................................... 2 AMENDMENT TABLE ............................................................................................................
    [Show full text]
  • Shigella Diversity and Changing Landscape: Insights for the Twenty-First Century
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Frontiers - Publisher Connector REVIEW published: 19 April 2016 doi: 10.3389/fcimb.2016.00045 Shigella Diversity and Changing Landscape: Insights for the Twenty-First Century Mark Anderson 1, 2, Philippe J. Sansonetti 1, 2, 3 and Benoit S. Marteyn 1, 2* 1 Institut Pasteur, Unité de Pathogénie Microbienne Moléculaire, Paris, France, 2 Institut National de la Santé et de la Recherche Médicale, Unité 786, Paris, France, 3 Collège de France, Paris, France Shigella is a pathovar of Escherichia coli comprising four groups, Shigella flexneri, Shigella sonnei, Shigella dysenteriae, and Shigella boydii, each of them, with the exception of S.sonnei, comprising several serotypes. Shigella accounts for the majority of dysentery causing infections occurring world-wide each year. Recent advancements in the Shigella field have led to a better understanding of the molecular mechanisms underlying host epithelial cell invasion and immune cell function manipulation, mainly using S. flexneri as a model. Host-cell invasion is the final step of the infection process, as Shigella’s virulence strategy relies also on its ability to survive hostile conditions during its journey through the gastro-intestinal tract, to compete with the host microbiota and to cross the intestinal mucus layer. Hence, the diversity of the virulence strategies among the different Shigella species has not yet been deeply investigated, which might be an important step to understand the epidemiological spreading of Shigella species worldwide and a key aspect for the validation of novel vaccine candidates. The recent development of high-throughput screening and sequencing methods will facilitate these complex comparison studies.
    [Show full text]
  • Meningococcal Disease Vibriosis
    2007 Indiana Report of Infectious Diseases All incidence rates throughout the report are per 100,000 population based on the U.S. Census Bureau’s population data as of July 1, 2007. Data for counties reporting fewer than five disease cases are not included to protect the confidentiality of the cases. Data for fewer than 20 reported disease cases are considered statistically unstable. References American Academy of Pediatrics. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006. Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. Centers for Disease Control and Prevention, Atlanta, GA, 2008. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W, Wolfe S, Hamborsky J, McIntyre L, eds. 11th ed. Washington DC: Public Health Foundation, 2009. Heyman, D.L. (2008). Control of Communicable Diseases Manual (19th ed.). American Public Health Association. Websites www.cdc.gov Animal Bites Cryptosporidiosis Anthrax Cyclosporiasis Arboviral Encephalitis Delta Hepatitis (hepatitis D) Babesiosis Dengue Fever and Dengue Hemorrhagic Fever Botulism Diphtheria Brucellosis Ehrlichiosis Campylobacteriosis Escherichia coli O157:H7 Cholera Haemophilus influenzae (invasive disease) Hantavirus Rabies Hepatitis A Rocky Mountain Spotted Fever Hepatitis B Rubella Hepatitis C Salmonellosis Hepatitis E Shigellosis Histoplasmosis
    [Show full text]
  • Cdc 7690 DS1.Pdf
    Dept* ENTEROBACTERIACEAE TAXONOMY AND NOMENCLATURE W. H. Ewing December 1966 U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE P u b l ic h e a l t h s e r v ic e BUREAU OF DISEASE PREVENTION AND ENVIRONMENTAL CONTROL N A T IO N A L COMMUNICABLE DISEASE CENTER Atlanta, Georgia 30333 CDCCfNTFRSFon OlS€*Si CONI not. INFORMATION CENTER ¿SWIC*, c D C Pn" f o r m aT. o W c Ï' n t e r 5 ■ ■ ■ DEPARTMENT OF HEALTH AND HUMAN SERVICES 134309 Public Health Service Centers for Disease Control Atlanta, Georgia 30333 QW 140 E95e 1966 Ewing, William H. (William Howell), 1914- QW 140 E95e 1966 Ewing, William H. (William Howell), 1914- Enterobacteriaceae 134309 DATE ISSUED TO ENTEROBACTERIACEAE TAXONOMY AMD NOMENCLATURE W. H. Ewing Enteric Bacteriology Laboratories National Communicable Disease Center, Atlanta, Georgia 30333 Definition (revised) of the family Enterobacteriaceae The family Enterobacteriaceae consists of gram negative, asporogenous, rod-shaped bacteria that grow well on artificial media. Some species are atrichous, and nonmotile variants of motile species also may occur. Motile forms are peritrichously flagellated. Nitrates are reduced to nitrites, and glucose is fermented with the formation of acid or of acid and gas. The indophenol oxidase test is negative and neither pectate nor alginate is liquefied. TAXONOMY At the outset a differentiation should be made between what is meant by Taxonomy and what is meant by Nomenclature. While these two fields or areas are closely related, a clear line of distinction may be drawn between them. One may establish a taxonomic system for a group of related microorganisms and use the letters of an alphabet, Arabic or Roman numerals, the names of places, or practically any other kind of designation one wishes for the dif­ ferent biotypes, serotypes, bacteriophage types, etc.
    [Show full text]